Alternative Energy Partners, Inc. (OTCPINK: AEGY) saw its share volume explode on May 29th with 236,199,621 shares exchanging hands, more than double its three month daily average volume of 77,561,562 shares.
AEGY's PharmaJanes(tm) provides a technology platform that facilitates patient enrollment in its exclusive network of dispensaries by processing and verifying patients' applications. In addition, PharmaJanes(tm) routes customer orders to its exclusive non-profit collectives, which then process and deliver the orders to patients in their homes. Upon completion of verification, patients have access to all medical cannabis products available on the PharmaJanes(tm) menu. PharmaJanes(tm) features products produced by master growers, and products licensed by SKTO to its wholesale-managed collectives.
PharmaJanes'(tm) online ordering platform allows authorized medical marijuana patients to order, process and pay for their authorized needs, in a simple, safe and secure ordering and payment interface. Simple Prepay(tm), a separate division of AEGY, is a merchant payment solution developed to offer a convenient payment solution to medical cannabis dispensaries, collectives, and delivery services. PharmaJanes(tm) also is the exclusive online marketing platform for Medical Greens(tm), a subsidiary of SKTO.
AEGY closed the day at $.0034, 30.77% higher than its previous close of $.0026.
PennyPickAlerts.com is one of the most talked about stock newsletters in the world. To receive 100% FREE stock alerts that have incredible potential, sign up here:
Creative Edge Nutrition Sees Share Volume Cut In Half
Creative Edge Nutrition, Inc. (OTCPINK: FITX) saw its share volume slide on May 29th with 22,273,859 shares exchanging hands, significantly lower than its three month daily average volume of 53,581,843 shares.
Just last week, FITX announced that it has elected Dr. M. Kerry O'Banion, M.D., Ph.D. to its Board of Directors.
"We are very fortunate to welcome such a respected industry leader to serve on our Board," stated Bill Chaaban, President & CEO. "Dr. Obanion brings both clinical knowledge and business acumen to CEN Biotech. He has his finger on the pulse of cutting edge treatment for patients living with neurological conditions and will undoubtedly be a critical resource for our development and use of providing ground breaking medicinal cannabis solutions."
FITX closed the day at $.0684, 9.64% lower than its previous close of $.0757.
Cannabis Science Working With Mediweit
Cannabis Science, Inc. (OTCPINK: CBIS) saw its share volume cut in half on May 29th with 5,858,183 shares exchanging hands compared to its three month daily average volume of 10,346,028 shares.
Cannabis Science recently announced they are working closely with Mediwiet and its founder, Mr. Wernard Bruining, on the building blocks necessary for the launch of the Clinical Observational Study, as previously announced.
Mediwiet patients, unlike most who receive medicinal cannabis distributed by pharmacies or dispensaries in the Netherlands, only use non-smokable, orally taken, cannabis products. The vast majority of Mediwiet patients have never smoked cannabis and have no history of previous recreational use.
The observational study will aim to provide observational data from patients who use cannabis products seeking treatment of pain and a wide range of severe illnesses such as cancer, Alzheimer's disease, Parkinson's disease, epilepsy and multiple sclerosis. The parties are also discussing a potential research project with the Dutch Association of Lyme Disease Patients who have recently started using cannabis-based medication in order to relieve pain and reduce inflammation stimulated by the bacterial infection.
CBIS closed the day at $.084.
Pennypickalerts.com issues momentum alerts on stocks that can provide gains to day traders.
Pennypickalerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more.
Pennypickalerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Pennypickalerts.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the Pennypickalerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Pennypickalerts.com believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.pennypickalerts.com
Pennypickalerts.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always own due diligence with any potential investment.